12.06.2014 • NewsBASFConstruction ChemicalsDede Willams

BASF, Lafarge in Iraq Construction Chemicals JV

BASF and Lafarge have announced plans for a new construction chemicals joint venture at Erbil in the autonomous Iraqi region of Kurdistan.


The new partnership links the world's largest producers of construction chemicals with the cement and concrete materials market leader. The two companies have worked together for many years.

BASF said the new facility will mainly produce concrete admixtures and cement additives. Alongside the plant's output, the German group will market its own portfolio of construction chemicals locally.

For BASF, the joint venture offers the opportunity to further tap into Iraq's growth market together with a strong partner already well-established in the region, said Dick Purchase, head of the construction chemicals division in Middle East, West Asia, CIS & Africa.

"This initiative clearly represents BASF's interest and commitment to the Middle East," Purchase said. He added that, "we are fulfilling our Master Builders Solutions promise of connectedness by being closer to our clients, providing our innovative and sustainable solutions and creating new job opportunities in the region."

Under the Master Builders Solutions brand, BASF bundles its advanced chemical solutions for new construction, maintenance, repair and renovation of structures. The portfolio ranges from chemicals, plastics, performance products and crop protection productsto oil and gas.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read